» Articles » PMID: 25610441

CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis

Overview
Journal Front Immunol
Date 2015 Jan 23
PMID 25610441
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-1 infection results in chronic activation of cells in lymphoid tissue, including T cells, B-cells, and myeloid lineage cells. The resulting characteristic hyperplasia is an amalgam of proliferating host immune cells in the adaptive response, increased concentrations of innate response mediators due to viral and bacterial products, and homeostatic responses to inflammation. While it is generally thought that CD4 T cells are greatly depleted, in fact, two types of CD4 T cells appear to be increased, namely, regulatory T cells (Tregs) and T follicular helper cells (Tfh). These cells have opposing roles, but may both be important in the pathogenic process. Whether Tregs are failing in their role to limit lymphocyte activation is unclear, but there is no doubt now that Tfh are associated with B-cell hyperplasia and increased germinal center activity. Antiretroviral therapy may reduce the lymphocyte activation, but not completely, and therefore, there is a need for interventions that selectively enhance normal CD4 function without exacerbating Tfh, B-cell, or Treg dysfunction.

Citing Articles

Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress.

Cheng S, Wang H, Kang X, Zhang H Pharmaceutics. 2024; 16(2).

PMID: 38399305 PMC: 10892906. DOI: 10.3390/pharmaceutics16020251.


SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise.

Duerr R, Crosse K, Valero-Jimenez A, Dittmann M Microorganisms. 2021; 9(7).

PMID: 34198973 PMC: 8307803. DOI: 10.3390/microorganisms9071389.


Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.

Peng X, Ouyang J, Isnard S, Lin J, Fombuena B, Zhu B Front Immunol. 2021; 11:596631.

PMID: 33384690 PMC: 7770166. DOI: 10.3389/fimmu.2020.596631.


Increased Regulatory T-Cell Activity and Enhanced T-Cell Homeostatic Signaling in Slow Progressing HIV-infected Children.

Roider J, Ngoepe A, Muenchhoff M, Adland E, Groll A, Ndungu T Front Immunol. 2019; 10:213.

PMID: 30809229 PMC: 6379343. DOI: 10.3389/fimmu.2019.00213.


Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV.

Filaci G, Fenoglio D, Taramasso L, Indiveri F, Di Biagio A Front Immunol. 2018; 9:2447.

PMID: 30459765 PMC: 6232923. DOI: 10.3389/fimmu.2018.02447.


References
1.
Molina J, Scadden D, Amirault C, Woon A, Vannier E, Dinarello C . Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells. J Virol. 1990; 64(6):2901-6. PMC: 249473. DOI: 10.1128/JVI.64.6.2901-2906.1990. View

2.
Zaunders J, van Bockel D . Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease. Front Immunol. 2013; 4:95. PMC: 3633949. DOI: 10.3389/fimmu.2013.00095. View

3.
Nurieva R, Podd A, Chen Y, Alekseev A, Yu M, Qi X . STAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function. J Biol Chem. 2012; 287(14):11234-9. PMC: 3322890. DOI: 10.1074/jbc.M111.324046. View

4.
Orsilles M, Pieri E, Cooke P, Caula C . IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy. APMIS. 2006; 114(1):55-60. DOI: 10.1111/j.1600-0463.2006.apm_108.x. View

5.
Hashmi M, Van Veldhuizen P . Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma. Expert Opin Biol Ther. 2010; 10(5):807-17. DOI: 10.1517/14712598.2010.480971. View